Company intelligence / Profile preview

Yaohai Bio-pharmaceutical

Taizhou, Jiangsu, Chinayaohai-bio.com.cn ↗

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Yaohai Bio-Pharma has successfully completed multiple clinical trials, including Phase III and Phase II projects, and has a strong focus on microbial expression systems for biologics production.

Therapeutic areas: Cardiovascular
Modalities: Recombinant proteinspeptidespolypeptidesenzymessingle-domain antibodies (sdAbs)plasmid DNAmRNAglyco-polymersvirus-like particles (VLPs)
Industry: Biotech

Partnerships

Humanwell HealthcareTaslyYabaoTopAllianceSinopharm

Beyond the preview

Go deeper on Yaohai Bio-pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yaohai Bio-pharmaceutical.

Explore the full profile